alexa Study On The Noninvasive Markers Of Liver Fibrosis And Inflammation In Chronic Hepatitis B Patients | 63995
ISSN: 2161-0517

Virology & Mycology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

9th International Virology Congress and Expo
March 13-14, 2017 London, UK

Weifeng Liang
Zhejiang University, China
ScientificTracks Abstracts: Virol Mycol
DOI: 10.4172/2161-0517.C1.017
Abstract
Liver biopsy is the gold standard in assessing histological abnormalities of the liver. The widely accepted indicator for antiviral therapy for chronic hepatitis B (CHB) in China is that the serum alanine aminotransferase (ALT) is more than two times the upper limit of normal (ULN). Although the role of ALT as an effective predictor of liver inflammation has been not definitively proven. It needs more effective non-invasive markers for assessing liver inflammation and fibrosis. We retrospectively evaluated noninvasive markers of treatment-naïve CHB patients who had done liver biopsy from October 2010 to October 2015. And our aim is to investigate the characteristics of histological abnormalities and find effective indicators to assess liver inflammation and fibrosis. Significant liver abnormality was defined as necroinflammation grade ≥A2 and/or fibrosis stage≥F2. A total of 522 CHB patients were recruited, 268 had normal ALT, 164 had 1-2×ULN ALT and 90 had ALT more than 2×ULN. Serious inflammation and fibrosis could be found in the patients with ALT that less than twice ULN. There are significant differences in age, platelet count (PLT), ALT, aspirate aminotransferase (AST), aspartate aminotransferase and alanine aminotransferase ratio (AAR), aspartate aminotransferase to platelet ratio index (APRI), and fibrosis index based on the 4 factor (FIB-4) between patients with mild and serious necroinflammation , and AST was the independent risk factor in predicting serious necroinflammation. The cut-off value of serious necroinflammation for AST was 29.5 U/L. The differences of age, older than 40 or not, PLT, ALT, AST, APRI, FIB-4 and HBV-DNA were statistically significant, and PLT was an independent factor in assessing the fibrosis stage.A high proportion of CHB patients with normal and 1-2×ULN ALT have serious liver histological abnormalities. AST could be an effective non-invasive marker for liver inflammation for treatment-naïve CHB patients and there is serious liver inflammation in CHB patients with AST more than 29.5U/L.
Biography

Weifeng Liang has completed his PhD in 1997 from Zhejiang University, China. He is the doctoral tutor, professor of Zhejiang University. He is the deputy director of both State Key Laboratory for Diagnosis and Treatment of Infectious Diseases and Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases of China. He is the director of Shengzhou Branch of The First Affiliated Hospital of Zhejiang University as well. He has published more than 70 papers in reputed journals and has been serving as an editorial board member of repute. He made outstanding contributions to the prevention and treatment of infectious diseases, especially viral hepatitis and AIDS.

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version